ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 10,300 shares, a growth of 22.6% from the November 30th total of 8,400 shares. Based on an average daily trading volume, of 12,700 shares, the short-interest ratio is presently 0.8 days.

Institutional Trading of ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC bought a new position in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned approximately 4.78% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent reporting period.

ProShares UltraShort Nasdaq Biotechnology Trading Down 0.4 %

Shares of ProShares UltraShort Nasdaq Biotechnology stock traded down $0.08 on Tuesday, hitting $18.34. The company had a trading volume of 3,237 shares, compared to its average volume of 14,055. ProShares UltraShort Nasdaq Biotechnology has a 52 week low of $14.05 and a 52 week high of $21.10. The business has a 50-day simple moving average of $16.38 and a 200-day simple moving average of $15.74.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The company also recently declared a dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd will be paid a dividend of $0.2064 per share. This is a positive change from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date of this dividend is Monday, December 23rd.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.